NEWSROOM
-
Title
-
- The Self-Developed Human Pancreatic Cancer 6-Gene Detection Kit by Fudan University Shanghai Cancer Center Secures Filing Approval, Breaking the Dilemma of Precision Diagnosis and Treatment for the "King of Cancers"
- Sensory Neurons Help Tumors Evade Immunotherapy in Triple-Negative Breast Cancer
- 'China solution' targets high-risk breast cancer
- FUSCC’s TORCH‑E Study Published in Clinical Cancer Research: 72.7% Complete Response Rate in Early Low Rectal Cancer
- A “Mount Everest–Level” Surgical Demonstration at the 36th Italian Congress of Digestive Surgery
- A Multi-Cohort Analysis from "Fudan University Shanghai Cancer Center" Reveals Global Patterns in Genomic Mutations among Patients with Early-Onset Colorectal Cancer
- Fudan University Team Led by Sheng Weiqi and Xu Midie Reports CCT6A Modulates Tumor Microenvironment via Intercellular Shuttling, Establishing a Pro-Tumor "Metabolic Niche"
- Fudan University Shanghai Cancer Center Convenes Virtual Meeting with Centre Antoine Lacassagne to Forge Future Collaboration
- Fudan University Shanghai Cancer Center Breakthrough Discovery: “Metabolic Waste” Offers New Hope for Immunotherapy in "King of Cancers"
- Nature | Xu Yanhui team uncovers the dynamics of RNA polymerase III transcription initiation